Instalab
logoInstalab

Isocitric Acid

Urine Test
Explore emerging links between energy metabolism, artery stiffness, and kidney health.
4.8 (3,295 reviews)
Tested by Genova Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Isocitric Acid test?

This test is most useful if any of these apply to you.

Already Running an Organic Acids Test
You can place this result beside related compounds, while recognizing that the pattern doesn't measure energy production directly.
Watching Your Kidney Numbers
Lower excretion has been studied in chronic kidney disease, but your result needs the context of eGFR and urine albumin.
Curious About Research on Artery Health
A study linked higher urine levels with arterial stiffness; using this result to predict your heart risk remains unproven.
Exploring Your Cellular Energy Metabolism
This is an exploratory addition to an organic acids profile, with no proven target or routine tracking schedule.

About Isocitric Acid

Urinary isocitric acid is one of the compounds reported on some organic acids panels. Researchers have studied it in relation to arterial stiffness and kidney disease, but its usefulness for preventive screening remains unproven. A result doesn't establish how efficiently your cells make energy or identify an organ that's under strain.

This is a research-stage marker. Studies have described its distribution in healthy people, but there is no validated target for improving health or evidence that adjusting treatment to this number improves outcomes.

Where Isocitrate Comes From

Mitochondria are compartments inside cells that produce much of the energy your body uses. They contain the citric acid cycle, a series of chemical reactions involved in extracting energy from food. Isocitrate forms when citrate is rearranged during this cycle.

The protein isocitrate dehydrogenase helps convert isocitrate to alpha-ketoglutarate. Some forms of this protein can also run the reaction in reverse, so describing every isocitrate reaction as a one-way step is inaccurate.

The amount reaching your urine depends on metabolism and kidney handling. A urine concentration therefore doesn't directly measure how quickly the cycle is running inside a particular tissue. Comparing neighboring compounds can describe a pattern, but it can't establish where a reaction is slowing.

Quantitative urine organic acid testing uses laboratory techniques that separate and identify individual compounds. Results are commonly expressed relative to urine creatinine. This helps account for urine dilution, although creatinine also varies with muscle mass, age, and kidney function. A spot-sample ratio and the total amount excreted over 24 hours are different measurements.

Arterial Stiffness

In a study of 330 Korean adults attending routine checkups, higher urine isocitrate was associated with greater arterial stiffness. Researchers measured stiffness using the speed of a pressure wave traveling from the arm to the ankle. The association remained after accounting for several cardiovascular risk factors and medications.

The study measured urine and arterial stiffness at the same point in time. It couldn't establish which changed first, whether isocitrate contributed to stiffness, or whether the urine result predicted future heart attacks. Proposed explanations involving altered enzyme activity were hypotheses, not findings demonstrated in participants' blood vessels.

Kidney Function

In a study of adults with stage 3 to 4 chronic kidney disease without diabetes, 24-hour urinary isocitrate excretion was about 41% lower than in healthy controls. Lower excretion was also found in an independent cohort. Separate kidney tissue analyses showed reduced expression of several genes involved in the citric acid cycle.

These findings support a connection with altered kidney metabolism. They don't establish low urinary isocitrate as a diagnostic test for kidney disease. The study's 24-hour excretion measurements also can't be treated as equivalent to a creatinine-adjusted spot urine result.

What Diabetes Studies Measured

Studies in type 2 diabetes have linked other urinary citric acid cycle compounds to worsening kidney function. An earlier study found associations involving fumarate and malate, while people whose kidney function worsened had lower citrate. A later, larger investigation also associated higher fumarate and lower citrate with worsening kidney outcomes.

Those studies didn't measure isocitrate. Their findings don't establish that higher urine isocitrate predicts diabetic kidney disease, or that all compounds in this cycle move in the same direction.

Blood Findings Are a Different Measurement

Plasma isocitrate has been studied more directly in relation to later disease. In a Spanish study of adults at high cardiovascular risk, people in the highest quarter of plasma isocitrate had about 2.6 times the odds of developing heart failure compared with those in the lowest quarter during roughly a decade of follow-up. This was an observational association.

Another study followed 309 people for several years after an acute coronary event. Higher plasma isocitrate was associated with cardiovascular events and death, but the associations were no longer statistically significant after accounting for kidney filtration. The cardiovascular-event association also didn't survive correction for the number of comparisons tested.

Plasma studies have also reported associations with future type 2 diabetes and fatty liver disease. The baseline diabetes association didn't remain statistically significant after correction for multiple comparisons. The small fatty liver study found higher plasma isocitrate in affected participants but didn't establish that it could distinguish simple fat accumulation from liver inflammation.

Blood and urine results reflect different aspects of metabolism and kidney handling. These plasma findings don't validate urinary isocitrate for predicting heart failure, diabetes, or liver disease.

When Results Can Be Misleading

  • Urine dilution and creatinine: dividing by creatinine reduces the influence of dilution but doesn't remove every source of variation. Changes in the denominator can change the reported ratio.
  • Diet and medication changes: feeding and prescription-drug studies have changed urinary isocitrate or closely related measurements. Such changes don't automatically represent improved or worsening health.
  • Illness and collection conditions: illness can change organic acid patterns. Its effect depends on the clinical situation; an illness-associated pattern may be useful when investigating a suspected metabolic disorder.
  • Age: children's urine organic acid patterns change with age. Adult research findings shouldn't be used to interpret a child's result.
  • Different measurements: an individual isocitrate result, a combined citrate/isocitrate signal, and a 24-hour excretion total are not interchangeable. Differences in separation, calibration, and reporting can also limit comparisons across laboratories.

What a Trend Can Mean

Repeated measurements can show whether a finding persists under similar conditions. They don't establish whether the change represents better energy production or lower disease risk. Isocitrate-specific thresholds for a clinically meaningful change haven't been established, and variation estimates from urine albumin, amino acids, or kidney stone testing can't supply them.

The opposing associations reported in arterial stiffness and established kidney disease are another reason to avoid treating either direction as universally desirable. A trend needs context from your health history and established measures of the condition you're evaluating.

What Moves This Biomarker

Evidence-backed interventions that affect your Isocitric Acid level

↓ Decrease
Traditional Korean diet for one month
A randomized crossover feeding study reported a small fall in urine isocitrate during the traditional Korean diet period, alongside improved blood lipids. The lipid changes were favorable, but whether the associated decrease in isocitrate reflects a health benefit is unproven.
DietModest Evidence

Frequently Asked Questions

References

17 studies
  1. Ji-hee Haam, Young-sang Kim, Doo-yeoun Cho, Hyejin Chun, Sang-woon Choi, Yun Kyong Lee, Sang Wook Lim, Hyung Suk Koo, Moon Jong KimScientific Reports2021
  2. Dimitris Tsoukalas, Athanasios K Alegakis, Persefoni Fragkiadaki, Evangelos Papakonstantinou, Dragana Nikitovic, Aikaterini Karataraki, Alexander E. Nosyrev, Emmanouel Papadakis, Demetrios a. Spandidos, Nikolaos Drakoulis, Aristidis Michael TsatsakisInternational Journal of Molecular Medicine2017
  3. Stein Ivar Hallan, Maryam Afkarian, Leila R. Zelnick, Bryan R. Kestenbaum, Shoba Sharma, Rintaro Saito, Manjula Darshi, Gregory a. Barding, Daniel Raftery, Wenjun Ju, Matthias Kretzler, Kumar Sharma, Ian H. De BoerEbiomedicine2017
  4. Crystal C. Tyson, Alison Luciano, Jennifer L. Modliszewski, David L. Corcoran, James Ralph Bain, Michael J. Muehlbauer, Olga Ilkayeva, Shirin Pourafshar, Jenifer Allen, Cassandra Bowman, Joseph Gung, John Robert Asplin, Jane Pendergast, Laura P. Svetkey, Pao-hwa Lin, Julia J. SciallaAmerican Journal of Kidney Diseases2021
  5. Sukyung Chun, Phil-kyung Shin, Myung-sunny Kim, Min Jung Kim, Hae-jeung Lee, Seon-joo Park, Dae-young Kwon, Sang-woon ChoiCurrent Developments in Nutrition2020

Isocitric Acid Testing Options

$405

See the chemical trail your metabolism leaves behind, and explore where your energy, gut, and nutrient pathways may be under strain.

Includes 49 biomarkers:
Isocitric Acid3-Indoleacetic AcidPhenylacetic AcidDHPPA3-Hydroxyphenylacetic Acid
$509

A comprehensive at-home nutritional and metabolic assessment that analyzes key biomarkers to reveal functional nutrient needs and imbalances.

90 biomarkers
FSA/HSA eligible
No Rx needed
HIPAA compliant